Carmine SELLERI | HEMATOLOGY, ONCOHEMATOLOGY AND ONCOLOGY EXAM

cod. 1060100094

HEMATOLOGY, ONCOHEMATOLOGY AND ONCOLOGY EXAM

	1060100094
	DIPARTIMENTO DI MEDICINA, CHIRURGIA E ODONTOIATRIA "SCUOLA MEDICA SALERNITANA"
	EQF7
	MEDICINE AND SURGERY
	2021/2022

PERCORSO SHARED STUDY PATHWAY

	OBBLIGATORIO
	YEAR OF COURSE 4
	YEAR OF DIDACTIC SYSTEM 2016
	SPRING SEMESTER

TEACHING UNITS

	SSD	CFU	HOURS	ACTIVITY	TYPE OF ACTIVITY
1	ONCOLOGIA EMATOONCOLOGIA E MALATTIE DEL SANGUE - MOD ONCOLOGIA MEDICA
	MED/06	3	36	LESSONS	COMPULSORY SUBJECTS, CHARACTERISTIC OF THE CLASS
2	ONCOLOGIA EMATOONCOLOGIA E MALATTIE DEL SANGUE - MOD MALATTIE DEL SANGUE
	MED/15	3	36	LESSONS	COMPULSORY SUBJECTS, CHARACTERISTIC OF THE CLASS

PROFESSORS

	CARMINE SELLERI2 T Curriculum
	STEFANO PEPE1 Curriculum

	Objectives
	THE PROFESSIONAL TRANING ACTIVITY HAS THE PURPOUSE OF PROVIDING CLINICAL AND LABORATORY DATA USEFULL TO GIVE THE ESSENTIAL DIAGNOSTIC ELEMENTS FOR THE CORRECT STAGING, PROGNOSIS, STRATEGY AND THERAPEUTIC RESPONSE OF OF HEMATHOLOGICAL AND ONCOLOGICAL HEMOPATHIES.

	Prerequisites
	THE STUDENT MUST ALREADY HAVE ACQUIRED, THROUGH THE PREVIOUS COURSES, THE NOTIONS OF BIOLOGY REGARDING THE GENERAL MECHANISMS OF THE NEOPLASTIC TRANSFORMATION AND THE PHYSIOPATHOLOGY OF THE TUMOR DISEASES, SUCH AS HEMATOLOGICAL DISEASES AND THE MOST IMPORTANT SOLID TUMORS. IN ADDITION, THE STUDENT SHOULD KNOW THE PHYSIOPATHOLOGY OF COAGULATION DISEASES, AS WELL AS THE MECHANISM OF ACTION OF THE MOST IMPORTANT CLASSES OF ANTINEOPLASTIC DRUGS.

THE STUDENT MUST ALREADY HAVE ACQUIRED, THROUGH THE PREVIOUS COURSES, THE NOTIONS OF BIOLOGY REGARDING THE GENERAL MECHANISMS OF THE NEOPLASTIC TRANSFORMATION AND THE PHYSIOPATHOLOGY OF THE TUMOR DISEASES, SUCH AS HEMATOLOGICAL DISEASES AND THE MOST IMPORTANT SOLID TUMORS. IN ADDITION, THE STUDENT SHOULD KNOW THE PHYSIOPATHOLOGY OF COAGULATION DISEASES, AS WELL AS THE MECHANISM OF ACTION OF THE MOST IMPORTANT CLASSES OF ANTINEOPLASTIC DRUGS.

	Contents
	HEMATOLOGY PROGRAM: THE COURSE WILL BE ON EPIDEMIOLOGY, NATURAL HISTORY, DIAGNOSIS, STAGING, PROGNOSIS AND PRINCIPLES OF THERAPY OF NEOPLASTIC HEMOPATHIES, AND OF NON-NEOPLASTIC EMOPATHIES AND OF THE HEMOSTASIS DISEASES PROGRAM OF THE HEMATO-ONCOLOGY COURSE AND BLOOD DISEASES: FERROCARENTIAL ANEMIA MEGALOBLASTIC ANEMIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IMMUNOLOGICAL HEMOLITIC ANEMIAS DREPANOCYTOSIS SPHEROCITOSIS TALASSEMIC SYNDROMES APLASTIC ANEMIA ACUTE LYMPHOID LEUKEMIA ACUTE MYELOID LEUKEMIA CHRONIC MYELOID LEUKEMIA CHRONIC LYMPHATIC LEUKEMIA MIELOPROLIFERATIVE SYNDROMES: POLYCYTEMIA, TROMBOCYTEMIA, MYELOFIBROSIS MYELODYSPLASTIC SYNDROMES MULTIPLE MYELOMA AND IMMUNOPROLIFERATIVE SYNDROMES HODGKIN LINFOMA NON HODGKIN LYMPHOMAS THROMPOCYTOPENIC DISORDERS HEMOPHILIA A, B AND VON WILLEBRAND DISEASE THE VENOUS AND ARTERIOUS TROMBOEMBOLISM: PROPHYLAXIS AND THERAPY HEMATOPOIETIC STEM CELL TRANSPLANT ONCOLOGY PROGRAM: GENERAL PART. PRINCIPLES OF BIOLOGY OF TUMORS: MECHANISMS OF NEOPLASTIC TRANSFORMATION, INVASION AND METASTASIS. PRINCIPLES OF EPIDEMIOLOGY OF TUMORS. TUMOR PREVENTION: PRIMARY PREVENTION, SECONDARY PREVENTION (SCREENINGS) AND CHEMOPREVENTION. CLINICAL APPROACH TO THE PATIENT WITH NEOPLASIA: DIAGNOSIS, STAGING, PROGNOSTIC FACTORS AND PREDICTIVE FACTORS, THERAPEUTIC PLANNING. PRINCIPLES OF ANTI-TUMORAL THERAPY: ROLE OF RADIOTHERAPY, SURGERY AND MEDICAL THERAPIES. RATIONAL BASES OF THE MEDICAL THERAPY OF NEOPLASMS: ADAPTIVE THERAPY, NEOADJUVANT THERAPY, THERAPY OF ADVANCED DISEASE. CHEMOTHERAPY; HORMONE THERAPY; THERAPY WITH NEW MOLECULAR TARGET DRUGS. SIDE EFFECTS OF DRUGS. PRINCIPLES OF SUPPORT THERAPY. PRINCIPLES OF CLINICAL METHODOLOGY IN ONCOLOGY. SPECIAL PART DIAGNOSIS, STAGING AND TREATMENT OF THE FOLLOWING NEOPLASMS: BREAST TUMORS; LUNG TUMORS; GASTRO-INTESTINAL TUMORS (ESOPHAGUS, STOMACH, PANCREAS, COLON-RECT); PROSTATE CANCER; OVARIAN TUMORS; GERMINAL TUMORS, KIDNEY TUMORS; MELANOMA. THE PROFESSIONAL TRAINING ACTIVITIES WILL FOCUS ON THE MOST COMMON NEOPLASTIC HEMATOLOGICAL DISEASES AND SOLID TUMORS DIRECTLY TO THE PATIENT'S BED.

Contents

HEMATOLOGY PROGRAM:
THE COURSE WILL BE ON EPIDEMIOLOGY, NATURAL HISTORY, DIAGNOSIS, STAGING, PROGNOSIS AND PRINCIPLES OF THERAPY OF NEOPLASTIC HEMOPATHIES, AND OF NON-NEOPLASTIC EMOPATHIES AND OF THE HEMOSTASIS DISEASES
PROGRAM OF THE HEMATO-ONCOLOGY COURSE AND BLOOD DISEASES:
FERROCARENTIAL ANEMIA
MEGALOBLASTIC ANEMIA
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
IMMUNOLOGICAL HEMOLITIC ANEMIAS
DREPANOCYTOSIS
SPHEROCITOSIS
TALASSEMIC SYNDROMES
APLASTIC ANEMIA
ACUTE LYMPHOID LEUKEMIA
ACUTE MYELOID LEUKEMIA
CHRONIC MYELOID LEUKEMIA
CHRONIC LYMPHATIC LEUKEMIA
MIELOPROLIFERATIVE SYNDROMES: POLYCYTEMIA, TROMBOCYTEMIA, MYELOFIBROSIS
MYELODYSPLASTIC SYNDROMES
MULTIPLE MYELOMA AND IMMUNOPROLIFERATIVE SYNDROMES
HODGKIN LINFOMA
NON HODGKIN LYMPHOMAS
THROMPOCYTOPENIC DISORDERS
HEMOPHILIA A, B AND VON WILLEBRAND DISEASE
THE VENOUS AND ARTERIOUS TROMBOEMBOLISM: PROPHYLAXIS AND THERAPY
HEMATOPOIETIC STEM CELL TRANSPLANT

ONCOLOGY PROGRAM:
GENERAL PART.
PRINCIPLES OF BIOLOGY OF TUMORS: MECHANISMS OF NEOPLASTIC TRANSFORMATION, INVASION AND METASTASIS.
PRINCIPLES OF EPIDEMIOLOGY OF TUMORS.
TUMOR PREVENTION: PRIMARY PREVENTION, SECONDARY PREVENTION (SCREENINGS) AND
CHEMOPREVENTION.
CLINICAL APPROACH TO THE PATIENT WITH NEOPLASIA: DIAGNOSIS, STAGING, PROGNOSTIC FACTORS AND PREDICTIVE FACTORS, THERAPEUTIC PLANNING.
PRINCIPLES OF ANTI-TUMORAL THERAPY: ROLE OF RADIOTHERAPY, SURGERY AND MEDICAL THERAPIES.
RATIONAL BASES OF THE MEDICAL THERAPY OF NEOPLASMS: ADAPTIVE THERAPY, NEOADJUVANT THERAPY, THERAPY OF ADVANCED DISEASE.
CHEMOTHERAPY; HORMONE THERAPY; THERAPY WITH NEW MOLECULAR TARGET DRUGS. SIDE EFFECTS
OF DRUGS. PRINCIPLES OF SUPPORT THERAPY.
PRINCIPLES OF CLINICAL METHODOLOGY IN ONCOLOGY.

SPECIAL PART
DIAGNOSIS, STAGING AND TREATMENT OF THE FOLLOWING NEOPLASMS:
BREAST TUMORS;
LUNG TUMORS;
GASTRO-INTESTINAL TUMORS (ESOPHAGUS, STOMACH, PANCREAS, COLON-RECT);
PROSTATE CANCER;
OVARIAN TUMORS;
GERMINAL TUMORS,
KIDNEY TUMORS;
MELANOMA.
THE PROFESSIONAL TRAINING ACTIVITIES WILL FOCUS ON THE MOST COMMON NEOPLASTIC HEMATOLOGICAL DISEASES AND SOLID TUMORS DIRECTLY TO THE PATIENT'S BED.

	Teaching Methods
	DISCUSSION OF CLINICAL CASES

	Verification of learning
	DAILY PARTICIPATION IN THE EXPECTED NUMBER OF HOURS DEDICATED TO TRAINING PROFESSIONAL ACTIVITIES. ORAL EXAMINATION. EXAM TEST PASSED/FAILED

	Texts
	AMADORI G, EMATOLOGIA - LE BASI FISIOPATOLOGICHE MOLECOLARI E CLINICHE. EDITORE PICCIN, 2010. TURA S, LEZIONI DI EMATOLOGIA. EDITORE ESCULAPIO. VI EDIZIONE, 2011. CORE CURRICULUM. ONCOLOGIA CLINICA . AUTORI: BIANCO A.R., DE PLACIDO S., TORTORA G. MCGRAW-HILL COMPANIES (COLLANA MEDICINA), 2011

	More Information
	NEAL S. YOUNG, STANTON L. GERSON, KATHERINE A HIGH. CLINICAL HEMATOLOGY. ELSEVIER, 2006. OXFORD TEXTBOOK OF ONCOLOGY, SECONDA EDIZIONE AUTORI: RL SOUHAMI, I TANNOCK, P HOHENBERGER AND J-C HORIOT. OXFORD UNIVERSITY PRESS, 2001. PRINCIPLES AND PRACTICE OF ONCOLOGY. AUTORI: DEVITA, HELLMAN, AND ROSENBERG. LIPPINCOTT, 2011.

BETA VERSION Data source ESSE3 [Ultima Sincronizzazione: 2022-11-21]

Carmine SELLERI | HEMATOLOGY, ONCOHEMATOLOGY AND ONCOLOGY EXAM